NCX 4251

· Nicox Ophthalmics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NCX 4251, covering 2023-01-19 to 2023-01-19. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharitis [Phase 2]

See pricing